{
    "2021-07-08": [
        [
            {
                "time": "2023-10-04",
                "original_text": "重磅交易落地！一家困境反转的生物制品公司，拥有巨大上升空间！",
                "features": {
                    "keywords": [
                        "重磅交易",
                        "生物制品",
                        "困境反转",
                        "上升空间"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "华润收购博雅生物，国资委已原则同意",
                "features": {
                    "keywords": [
                        "华润",
                        "博雅生物",
                        "国资委",
                        "收购"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "血制品行业深度报告：国家生物安全战略物资，血制品行业迎来大机遇！【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "血制品",
                        "国家生物安全",
                        "战略物资",
                        "行业机遇"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "血制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "确认！华润医药收购博雅生物",
                "features": {
                    "keywords": [
                        "华润医药",
                        "博雅生物",
                        "收购"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "思享会｜7月新药研发行业盛宴，只差一个你",
                "features": {
                    "keywords": [
                        "新药研发",
                        "行业盛宴"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "新药研发"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}